SK bioscience Co.,Ltd. (KRX:302440)
50,300
-1,000 (-1.95%)
Last updated: Jun 23, 2025
SK bioscience Revenue
SK bioscience had revenue of 154.56B KRW in the quarter ending March 31, 2025, with 594.00% growth. This brings the company's revenue in the last twelve months to 399.83B, up 7.72% year-over-year. In the year 2024, SK bioscience had annual revenue of 267.55B, down -27.59%.
Revenue (ttm)
399.83B
Revenue Growth
+7.72%
P/S Ratio
9.86
Revenue / Employee
406.33M
Employees
984
Market Cap
3,941.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 267.55B | -101.96B | -27.59% |
Dec 31, 2023 | 369.51B | -87.22B | -19.10% |
Dec 31, 2022 | 456.73B | -472.28B | -50.84% |
Dec 31, 2021 | 929.00B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition